Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial
Volume 35 - Issue 2 - June 2020, Page 170-179
İlker Yağcı

Enter the code above.